Dextran-spermine cationic polysaccharide was prepared by means of reductive amination between oxidized dextran and the natural oligoamine spermine. The formed Schiff-base imine-based conjugate was reduced with borohydride to obtain the stable amine-based conjugate. The transfection efficiency of the synthetic dextran-spermine was assessed in vitro on HEK293 and NIH3T3 cell lines and found to be as high as the DOTAP/Chol 1/1 lipid-based transfection reagent. Modification of the dextran-spermine polycation with polyethylene glycol resulted in high transfection yield in serum-rich medium. Intramuscular injection in mice of dextran-spermine-pSV-LacZ complex induced high local gene expression compared to low expression of the naked DNA. Intravenous injection of a dispersion of the dextranspermine-pSV-LacZ complex resulted with no expression in all examined organs. When the partially PEGylated dextranspermine-pSV-LacZ complex was intravenously applied, a high gene expression was detected mainly in the liver. Preliminary targeting studies indicated that the PEGylated dextran-spermine-pSV-LacZ complex bound to galactose receptor of liver parenchymal cells rather than the mannose receptor of liver nonparenchymal cells. This work offers a new biodegradable polycation based on natural components, which is capable of transfecting cells and tissues in vitro and in vivo.
Introduction
DNA can be delivered into the cell nucleus using physical means or using specific carriers that carry the genes into the cells for gene expression. 1 Gene carriers are divided into two main groups: viral carriers where the DNA to be delivered is inserted into a virus, 2 and cationic molecular carriers that form an electrostatic interaction with the DNA. 3 From the various methods developed for delivering genes, gene carriers have been extensively investigated as transfecting agents for therapeutic genes in Gene Therapy. 4 Although at present, the in vivo expression levels of the synthetic molecular gene vectors are lower compared to viral vectors and gene expression is transient, these vehicles are likely to present several advantages including safety, low immunogenicity, capacity to deliver large genes, and largescale production at low cost. 5 The two leading classes of synthetic gene delivery systems that have been mostly investigated involve the use of either cationic lipids or cationic polymers. 1 Polycations used for gene delivery are considered to be promising candidates for nonviral gene delivery in part because of their molecular diversity that can be modified to fine-tune their physicochemical properties. 6, 7 These polycations are able to condense large genes into compact structures and to mask the negative DNA charges, necessities for transfecting most types of cells. 8, 9 Polycations used for gene complexation are polyamines that become cationic at physiologic conditions. The most studied polycations used for gene complexation and delivery are the branched/linear polyethylene imine (PEI), 10, 11 poly(L-lysine), 12 poly (dimethyl aminoethyl methacrylate, pDMAEMA), 13 poly(trimethyl aminoethyl methacrylate, pTMAEMA), 14 poly(vinylpyridine), 15 chitosan, 16 and diethylaminoethyl dextran (DEAE-dextran). 17 Most polycations are toxic to cells and nonbiodegradable, while the polymers based on amino acids such as poly(lysine) are immunogenic. 12 More advanced polymeric gene delivery systems employ macromolecules with a very high cationic charge density that act as endosomal buffering systems, thus suppressing the endosomal enzyme activities and protecting the DNA from degradation. The high cationic charge mediates both DNA condensing and buffering capacities that diminish the requirement for the addition of endosomolytic agents. 18, 19 Success of nonviral gene delivery depends on the type of carrier materials to bind plasmid DNA and facilitate the cell-specific uptake of carrier-DNA complex. [20] [21] [22] In addition, the in vivo gene expression is greatly influenced by the body distribution of the carrier-DNA complex intravenously injected. The gene transfection with naked plasmid DNA always shows low efficiency in vivo although it is simple and safe. 23, 24 On the other hand, when a plasmid DNA is complexed with a vector, the molecular size and surface charge of the complex affect the body fate of the plasmid DNA. 25 For example, the complex of plasmid DNA with cationic liposomes mainly accumulates in the lung, liver, and spleen. 26, 27 In an attempt to alter the organ distribution of lipid complexes, their surface was modified by polyethylene glycol (PEG) and other hydrophilic polymers. 28, 29 This modification enabled the plasmid DNA to prolong the half-life in the blood circulation by suppressing their interaction with plasma components and erythrocytes, which strongly modifies the in vivo characteristics of DNA. The particle size, charge, and the surface characteristics of the complex have a strong influence on the plasmid DNA body distribution and transfection efficiency. 24, 26, [30] [31] [32] [33] In recent publications, 34, 35 we reported on a new class of biodegradable polycations capable of complexing and transfecting various genes to many cell lines in relatively high yields. More than 300 different polycations were prepared starting from various natural polysaccharides and oligoamines having two to four amino groups. These cationic polysaccharides were prepared by reductive amination of the oligoamine and periodate-oxidized polysaccharides. Although most of these cationic conjugates formed stable complexes with plasmid DNAs as determined by ethidium-bromide quenching assay, 36 only the dextran-spermine-based polycations were found to be highly effective in transfecting cells in vitro.
The main objective of this study was to evaluate the efficiencies of dextran-spermine in delivering genes in vivo after intramuscular (i.m.) and intravenous (i.v.) injection of its complex with plasmid DNA, and also to test the transfection efficiencies and biodistribution of PEGylated dextran-spermine-DNA complex relative to the corresponding non-PEGylated carrier after i.v. administration.
Results

Chemistry
Dextran-spermine-based conjugate ( Figure 1 ) was prepared by reductive amination between oxidized dextran and spermine. Dextran was initially oxidized with potassium periodate and the obtained dialdehyde derivative was allowed to react under basic conditions with spermine. Three dextran-spermine-based conjugates (G7TA103, G7TA107, and G7TA141) were prepared under similar conditions and characterized as illustrated in Table 1 . The content of substituted spermine moieties was determined from nitrogen content (% N) and found to be nearly 50% (50 spermine moieties in each 100 repeating sugar units).
The corresponding G7TA141 dextran-spermine polycation was further modified with increasing amount of PEG to obtain a partially shielded polycation. PEG monomethyl ether (mPEG, M w ¼2000 Da) was initially treated with p-nitrophenyl chloroformate to obtain the active p-nitrophenyl carbonate derivative (mPEG-OPNC) in relatively good yields (Figure 2a) . Substitution of the PEG moieties to dextran-spermine was simply achieved by mixing an aqueous solution of the mPEG-OPNC with a concentrate aqueous solution of the polycation at pH 9. The amount of PEG was fixed at 1, 3, and 5% (mol/mol) of PEG moieties to primary amines (e-NH 2 ), respectively. The mixture was allowed to stir at room temperature overnight, purified by column chromatography and lyophilized to dryness. The PEGylated dextran-spermine (Figure 2b ) derivatives show nearly similar molecular weights to the starting dextran-spermine (G8TA34A to G8TA34C, Table 1 ).
In vitro transfection
The in vitro transfection efficiency of the cationic dextran-spermine-based conjugates was tested in NIH3T3 and HEK293 cell lines applying p-luc and b-Gal encoding plasmid DNAs. Figure 3a shows the in vitro transfection efficiencies in serum-free medium Figure 1 Synthesis of dextran-spermine-based conjugate.
Dextran-spermine gene vector effective in mice H Hosseinkhani et al (SFM) of the representative dextran-spermine-based conjugates (G7TA141, G7TA107, and G7TA103, Table 1 ) in NIH3T3 cells applying p-luc as the marker gene. The purpose of this experiment was to evaluate the reproducibility in the transfection efficiency of the synthetic polycations. Transfection yields were recorded as a function of polycation/DNA weight-mixing ratios, and expressed as relative light units (RLU) normalized to the total protein contents in cell wells. At weightmixing ratio of 2 (polymer/DNA), negligible degree of transfection was observed in all conjugates. Maximum transfection was obtained in the range of 4-8 weightmixing ratios (polymer/DNA) and luciferase readings were similar to the positive control (ie DOTAP/Chol 1/ 1). At this range, nearly 7500 RLU/mg protein was obtained. Higher weight-mixing ratios (10-15, polymer/ DNA) resulted with a remarkable decrease in luciferase expression.
PEGylated dextran-spermine polycations were tested for their transfection activities both in SFM and 10% fetal calf serum (FCS). The active dextran-spermine polycation (G7TA141, Table 1 ) was modified with increasing amount of PEG (up to 5% mol/mol, Table 1 ), and the in vitro transfection efficiency in HEK293/b-Gal system was tested as functions of %PEGylation and medium type (Figure 3b ). The transfection efficiency of each PEGylated derivatives was recorded at the best weight-mixing ratio and expressed as OD at 420 nm (see Materials and methods) without normalization to total protein contents in cell wells. The non-PEGylated dextran-spermine polycation (ie G7TA141, 0% PEGylation) was used as positive reference in this experiment. As expected, Figure 3b ). PEGylated derivatives (1, 3, and 5% mol/mol) showed high transfection yields both in SFM and 10% FCS cultures. Also, it was noticed that minor differences in b-Gal expression in fullmedium cultures were monitored at all degrees of PEGylation.
In vivo studies
Intramuscular injection of dextran-spermine-pSVLacZ complex G7TA141 polycation (Table 1) was randomly selected for the in vivo studies and all in vivo injections were made in triplicate and average values and SD were recorded. Figure 4 In vivo b-Gal activities (mU/mg protein) of mice muscles as a function of weight-mixing ratio (polycation/DNA). Mice were intramuscularly injected with dextran-spermine-pSV-LacZ complex at weightmixing ratios of 0.25-10 (polycation/plasmid DNA) and the gene level was evaluated 2 days post injection. PBS, dextran-spermine (D-SPM) and free plasmid DNA solutions were injected as control references. Dextran-spermine gene vector effective in mice H Hosseinkhani et al dextran-spermine polycation did not induce gene expression in all tested organs (data not shown). Modification of the dextran-spermine polycations with the nonionic hydrophilic polymer PEG remarkably improved the transfection efficiency of the polycations in serum-rich media. Table 2 summarizes the in vivo gene expression of different organs 2 days after i.v. injection of PBS, free plasmid DNA, 5% PEGylated dextran-spermine polycation (without DNA), and the 5% PEGylated dextranspermine-pSV-LacZ complex. PBS, PEGylated polycation, as well as free-plasmid DNA did not induce any b-Gal activities in all tested organs. On the other hand, when 5% PEGylated dextran-spermine-pSV-LacZ complex was applied, a high gene level was observed in the liver. The b-Gal activity in the liver was calculated to be 28.4573.38 mU/mg protein in contrast to the free plasmid DNA and other controls (ie PBS and polycations), which resulted with negligible activities.
In another in vivo experiment, the level of gene expression in the liver after i.v. injection of PEGylated dextran-spermine-pSV-LacZ complex was monitored as a function of %PEGylation and time after treatment. Figure 6a shows the calculated b-Gal activities in the liver, 2 days after i.v. injection of PEGylated-dextranspermine-pSV-LacZ complex solutions. The percentages of PEGylated dextran-spermine were 1, 3 and 5% mol/ mol (PEG to e-NH 2 ). PBS, free plasmid DNA, and the PEGylated polycations (without DNA) solutions were similarly injected as controls and resulted as expected with no gene expression. In all, 1% PEGylated polymers showed minor transfection activity, while the 3 and 5% PEGylated dextran-spermine showed high b-Gal transfection yields of 23 and 30 mU/mg protein, respectively. Figure 6b shows the level of gene expression in the liver after i.v. injection of 5% PEGylated dextran-sperminepSV-LacZ complex solution as a function of time after treatment. The highest level of gene expression was obtained 2 days post injection.
To assess the reason for this liver targeting obtained with the PEGylated dextran-spermine gene carrier, the animals were pretreated with galactosylated and mannosylated agents that bind to liver galactose and mannose receptors, respectively. Figure 7 shows the gene expression of b-Gal in the liver 2 days after i.v. injection of 5% PEGylated-dextran-spermine-pSV-LacZ complex with and without preinjection of galactose and mannose agents. Without preinjection of the blocking agents, high b-Gal activity was observed in the liver (B30 mU/mg protein) similar to the results reported in Dextran-spermine gene vector effective in mice H Hosseinkhani et al Figure 6 . Preinjection with both arabinogalactan and Dgalactosylated bovine albumin resulted in a remarkable decrease of an average of 10 mU/mg protein in the b-Gal activity in the liver. In addition, when D-mannosylated bovine albumin that does not bind to liver galactose receptor was preinjected, high transfection yield was obtained.
Discussion
Dextran-spermine-based polycation was prepared by reductive amination synthesis between oxidized dextran (dialdehyde derivatives) and the naturally occurring tetramine spermine. The synthetic route of dextranspermine-based conjugates was found to be reproducible in terms of degree of conjugation and grafted spermine moieties (Table 1) . 34 The in vitro transfection efficiencies of the synthetic conjugates, on the other hand, were also found to be reproducible in terms of gene level, but the weight-mixing ratio needed for optimal transfection varied from polymer to polymer. The optimal weightmixing ratio needed for transfection in all tested dextran-spermine conjugates was found to be in the range of 4-8 (polymer/DNA). This variation could be explained by the slight changes in spermine content and degree of grafting, which in part could result with major changes in DNA-condensation properties.
When 10% FCS culture medium was applied instead of SFM in the in vitro transfection experiments, 80% reduction in the gene expression was observed ( Figure   3b ). This phenomenon is well known and is attributed to proteins (serum components) adsorption on the surface of the complex (ie polycation/DNA), which in part could induce the aggregation/deactivation of the complex and finally to the reduction in the transfection efficiencies. 37 In analogy to literatures, it was decided to modify our developed polycation with hydrophilic polymer such as PEG in order to increase their stability and transfection efficiencies in serum-rich media. 29, 37 PEG molecules are considered to be the most attractive materials for this purpose. They are safe, nontoxic, cheap, and do not interact with plasma components. 38 Transfection efficiencies in 10% FCS medium applying the PEGylateddextran-spermine polycations as the gene carriers resulted with the high gene level (Figure 3b) , indicating a remarkable increase in the complex stability. No remarkable differences in the gene level were observed with the all PEGylated derivatives (ie 1, 3, and 5% PEGylation).
Intramuscular injection of the dextran-spermine-pSVLacZ complex solution to mice resulted with a high local gene level in comparison to the naked DNA, which resulted with no gene expression. The optimal weightmixing ratio for proper expression was found to be 5 (polycation/DNA) applying 50 mg/mouse plasmid injected dose. The non-PEGylated dextran-spermine-pSVLacZ complex when applied by i.v. injection to mice did not show gene expression. Typical polycation-DNA complexes are believed to be rapidly removed from the bloodstream by the reticuloendothelial system, which decreases their potential for specific targeting in vivo. In analogy with STEALTH liposomes, it was suggested that incorporation of hydrophilic, nonionic polymer onto the surface of the complexes can help to solve this problem. 39 Therefore, PEGylated-dextran-spermine derivatives were synthesized as gene carriers for i.v. administration. Intravenous administration of the PEGylated dextranspermine-pSV-LacZ complex resulted with a high gene expression in the liver. The 5% PEGylated-dextranspermine was found to be the most active PEGylated derivative for systemic administration.
The gene expression in the liver by the PEGylated dextran-spermine-pSV-LacZ complex was markedly On the other hand, albumin bovine-a-D-mannopyranosyl phenyl isothiocyanate is bound to the mannose receptor, which is located on the surface of the nonparenchymal cells and responsible for this uptake. 42 Taken together, the present results strongly indicate that the targeting of PEGylated dextran-spermine-plasmid DNA complex to the liver is probably mediated by the galactose receptor of the liver parenchymal cells rather than the mannose receptor of liver nonparenchymal cells.
Materials and Methods
Chemistry
All solvent and reagents were of analytical grade and were used as received. Dextran with an average molecular weight of 40 kDa was obtained from Sigma Chemical Co. (St Louis, MO, USA). Potassium periodate (KIO 4 ), sodium borohydride (NaBH 4 ), mPEG (mPEG2000), p-nitrophenyl chloroformate and spermine were obtained from Aldrich (Milwaukee, WI, USA). Water-free mPEG2000 was obtained by azeotropic distillation from toluene and vacuum-dried at 601C over P 2 O 5 . A sage-metering pump model-365 (Orion, NJ, USA) was used for slow and reproducible addition of reactants. Oxidized dextran was obtained by reacting dextran with 1 equimolar of potassium periodate (to saccharide unit) in water followed by purification with DOWEX-1 anion-exchange chromatography (acetate form), dialysis against double-distilled water (DDW), and finally by lyophilization. The aldehyde content of the oxidized dextran was determined by the hydroxylamine hydrochloride method and found to be 6.970.6 mmol/g (aldehyde/1 g polymer, n¼5). 43 1 H-NMR spectra were recorded on Varian 300 MHz instrument using D 2 O or d 6 -DMSO as solvents and TMS as internal standard. Average molecular weights of polycations were estimated by GPC-Spectra Physics instrument (Darmstadt, Germany) consisting of a pump, column (Shodex KB-803) and refractive index (RI) detector. Average molecular weights were determined according to Pullulan standards (PSS, Mainz, Germany) with molecular weights between 5800 and 212 000 Da. A volume of 5% (w/v) Na 2 HPO 4 in 3% (v/v) acetonirile (pH 4) was used as an eluent for the cationic conjugates. 44 Degree of conjugation was estimated by elemental microanalysis of nitrogen (% N) using a Perkin-Elmer 2400/II CHN analyzer. Primary amine content (e-NH 2 ) in the polymer was determined by the TNBS method applying spermine tetrahydrochloride (Aldrich) as a standard. 45 
Synthesis of dextran-spermine conjugate
Dextran-spermine-based conjugate was prepared as described elsewhere. 34,35. Briefly, a solution of oxidized dextran (1 g) in 100 ml DDW (6.9 mmol aldehyde groups) was slowly added during 5 h to a basic solution containing 1.25 equimolar amount of oligoamine (to aldehyde) dissolved in 50 ml borate buffer (0.1 M, pH 11).
The mixture was stirred at room temperature for 24 h and excess of sodium borohydride (1 g) was added and stirring was continued for 48 h at room temperature. The reduction was repeated with additional portion of NaBH 4 (1 g) and stirring for 24 h under the same conditions. The resulting light-yellow solution was dialysed against DDW (6 Â 6 l) applying 3500 cutoff cellulose tubing (Membrane Filtration Products Inc., San Antonio, TX, USA) followed by lyophilization to obtain a yellowish reduced amine-based conjugate in 50% overall yield (to polysaccharide). 
Synthesis of methoxy PEG2000 terminated p-nitrophenyl carbonate (mPEG-OPNC)
Methoxy PEG2000 (5 g, 2.5 mmol of hydroxyl groups) was dissolved in 100 ml of anhydrous THF and 1.4 ml of anhydrous triethylamine (10 mmol) was added under nitrogen atmosphere. The mixture was cooled to 01C (ice bath) and 1.5 g of p-nitrophenyl chloroformate (7.5 mmol) was added and the mixture was stirred for 2 h at 01C and 16 h at room temperature. Triethylammonium hydrochloride salt was discarded by filtration and the filtrate was evaporated to dryness under reduced pressure. The crude was redissolved in dichloromethane (150 ml) and washed with 5% citric acid (2 Â 50 ml) and DDW (2 Â 50 ml). The organic phase was dried over anhydrous MgSO 4 , filtered, and concentrated under reduced pressure to a final volume of 15 ml. Precipitating of the product was achieved by dropwise addition of the concentrate solution into anhydrous diethylether (400 ml) and incubation at -201C for 24 h, followed by filtration and vacuum-dried over P 2 O 5 to yield 3.15 g (B60%) of the product. The degree of modification was calculated by UV spectrophotometer (l¼410 nm) after hydrolysis of the p-nitrophenyl carbonate group with 0.1 M NaOH (standardized p-nitrophenol solution in 0.1 M NaOH was used for the calibration curve). The degree of conversion was found to be approximately 97% relative to starting terminal hydroxyl functionalities. 
Synthesis of PEGylated dextran-spermine conjugates
Dextran-spermine conjugate (100 mg, B118 mmol of e-NH 2 ) was dissolved in 2.5 ml. DDW and the pH was adjusted to 9 by 1 M HCl aqueous solution. To this solution, 118 ml (1% mol/mol to e-NH 2 ) of mPEG-OPNC aqueous solution (21.76 mg/ml in DDW, equal to 10 mmol/ml) was added, and the mixture was stirred at room temperature for 16 h. The PEGylated derivative Dextran-spermine gene vector effective in mice H Hosseinkhani et al was purified from the released p-nitrophenol and unbound PEG by Sephadex G-25 column chromatography using DDW as the eluent. Fractions containing the PEGylated derivative (positive Ninhydrin test) were collected and lyophilized to dryness. This method was similarly adapted for other percents of PEG substitution (ie 3 and 5% mol/mol). The average yield of the synthesis was nearly 90% (w/w). The degree of PEGylation was found to be B95% (to starting feed) as determined by spectrophotometric measurement of the released p-nitrophenol (UV, l¼410 nm).
Preparation of plasmid DNA
The plasmid DNA used in this study was the expression vector consisting of the coding sequence of LacZ and an SV40 promoter inserted at the upstream (pSV-LacZ, 7931 bp). The plasmid DNA was amplified in a transformant of E. coli bacteria and isolated from the bacteria by Qiagen Maxi kit-25 (Qiagen KK, Tokyo, Japan). Briefly, the grown bacteria were harvested and lysed in the aqueous solution of 1 wt% sodium dodecyl sulfate (SDS) and 0.1 wt% RNase A solution in NaOH (pH 8.0). The lysate was neutralized by the addition of 3.0 M potassium acetate (pH 5.5). After separation of the insoluble portion by the use of the QIA filter cartridge, the lysate was applied to the Qiagen-tip (anion-exchange resin), followed by washing with a buffer containing 1 M NaCl to remove the trace of RNA and protein. The plasmid DNA was eluted with an elution buffer containing 1.25 M NaCl at pH 8.5, de-salted, and precipitated by 2-propanol. The precipitated plasmid DNA was centrifuged at 14 000 r.p.m. for 10 min at 41C and washed twice with 70% ethanol aqueous solution to substitute 2-propanol for ethanol. After centrifugation (14 000 r.p.m., 2 min, 41C), the resulting plasmid DNA was air-dried and dissolved in a small volume of 10 mM Tris-HCl and 1 mM EDTA buffer solution. When measured to assess the purity of plasmid DNA obtained, the absorbance ratio at the wavelength of 260 to 280 nm ranged from 1.8 to 2.0.
In vitro transfection
Transfection with dextran-spermine polycation was performed and analyzed using expression plasmid pCMV-luc containing luciferase gene under the control of cytomegalovirus long terminal repeat enhancer/promoters. A measure of 0.5 mg of purified plasmid (Qiagen kit) per well of transfected cells was mixed with dextranspermine (or PEGylated derivatives) at various weightmixing ratios ranging from 1 to 20 w/w (polycation/ DNA, respectively). The polycation/DNA complexes at particular weight ratios were diluted to a final volume of 200 ml with SFM and allowed to stand at room temperature for 30 min. The 24-well plates, seeded 24 h before the transfection with 1.5 Â 10 5 cells per well (NIH3T3 or HEK293), were washed with SFM and the solution of the complexes (at various polymer/DNA ratios) were added to the corresponding wells and incubated for 4 h at 371C under growth conditions. The medium containing the complexes was then replaced with 10% FCS and the cells were incubated in culture for 48 h. At this time, the growth medium was removed, and cell lysates were formed and analyzed for luciferase activity (Promega luciferase assay kit) and for total protein content (BCA assay, Pierce). pCMV-Gal encoding to b-galactosidase was also used in parallel experiments and the enzyme activity was measured using Invitrogen kit (Invitrogen Co., CA, USA). For the transfection experiments in serum-containing medium, SFM was replaced with 10% FCS at the complexation and uptake stages, followed by the same procedure described above.
DOTAP/Chol 1/1 transfecting reagent (Avanti Polar Lipids Inc., Alabaster, AL, USA) was used as positive control according to the manufacturer's protocol. Briefly, 2.32 ml of 1 mM DOTAP/Chol 1/1 solution in 10 mM HEPES buffer saline (pH 7.4) was added to 2 mg DNA solution and the mixture was diluted to 200 ml with the same buffer and allowed to stand at room temperature for 30 min. Then, it was added to cell well in SFM, incubated for 4 h and SFM was replaced with growth medium (10% FCS) and incubated for 48 h. Cells were lysed and the gene expression was evaluated as described above.
In vivo studies
Complexation of dextran-spermine with plasmid DNA for the in vivo studies was performed by mixing the two components at various weight-mixing ratios in the aqueous solution. Briefly, 150 ml of 0.1 M PBS (pH 7.4) containing 2.5, 5, 10, 25, 50, and 100 mg of dextranspermine was added to the same volume of PBS containing 10 mg of plasmid DNA. The solution was gently agitated at 371C for 30 min to form cationized dextran-plasmid-DNA complexes. Complexes having higher DNA content (up to 200 mg) were similarly formed as described above.
Intramuscular injection of dextran-spermine-DNA complexes
All the experimental procedures were performed in accordance with the specifications of Guideline for Animal Experiments of Kyoto University. DDy male mice (6 weeks old, body weight around 15 g, Shimizu Laboratory Supplies Co. Ltd, Kyoto, Japan) were anesthetized by intraperitoneal injection of pentobarbital (160 mg/kg body weight) and an incision was performed on the skin overlying the inguinal portion of the left leg. One thread was sutured on the left femoral muscle exposed to mark the site of DNA injection. The pSV-LacZcationized-dextran complexes containing different amounts of pSV-LacZ were intramuscularly injected at the sutured point. Mice were killed with cervical dislocation and the muscle samples (5 mm in diameter and 5 mm in depth) were taken around the marking points 0.5, 1, 2, 3, 4, and 5 days after DNA-complex injection.
Intravenous administration of PEGylated-dextranspermine-DNA complexes DDy male mice (6 weeks old, 20 g body weight) were used in this study. All mice received an i.v. injection of 0.1 M PBS (pH 7.4) or that containing free plasmid DNA, PEGylated-dextran-spermine and the PEGylated-dextran-spermine-plasmid DNA complex mixtures in a total volume of 200 ml. The complex was prepared at weight mixing ratio of 5 (polymer/plasmid) and the amount of plasmid DNA injected was fixed at 50 mg/ mouse. At 0.5-5 days post injections, mice were killed with cervical dislocation and the blood sample was taken out directly from the heart by syringe aspiration, and the organs and carcass (residual body portions) were taken Dextran-spermine gene vector effective in mice H Hosseinkhani et al and washed with PBS, frozen in liquid nitrogen, and stored at À851C.
Preadministration of galactosylated and mannosylated reagents
Arabinogalactan, albumin bovine-galactosamide and albumin bovine-a-D-mannopyranosylphenyl isothiocyanate were purchased from Sigma-Aldrich Japan KK (Tokyo, Japan).
Mice were intravenously injected with 100 ml of 20 mg/kg of arabinogalactan, albumin bovine-galactosamide and bovine albumin-a-D-mannopyranosylphenyl isothiocyanate in PBS. After 1 h, mice were administered with PBS, free plasmid DNA, PEGylated dextranspermine, and PEGylated dextran-spermine-plasmid DNA complex as described above. At 2 days post injection, mice were killed and the liver organs were taken out to evaluate the level of gene expression.
Evaluation of gene expression
For the evaluation of gene expression, b-galactosidase activity was determined using Invitrogen kit. Briefly, the muscle samples or other organs were immersed and homogenized in the lysis buffer (0.1 M Tris-HCl, 2 mM EDTA, 0.1% Triton X-100) at a lysis buffer volume (ml)/ sample weight (mg) ratio of 4:1 in order to normalize the influence of weight variance on the b-galactosidase assay. The sample lysate (2 ml) was transferred to a centrifuge tube, followed by freeze-and-thaw three times and centrifugation at 15 000 g at 41C for 5 min. The supernatant (30 ml) was mixed with 70 ml of 4 mg/ml o-nitrophenyl b-D-galactopyranoside (OPNG) aqueous solution and 200 ml of cleavage buffer (60 mM Na 2 H-PO 4 Á 7H 2 O, 40 mM NaH 2 PO 4 Á H 2 O, 10 mM KCl, and 1 mM MgSO 4 Á 7H 2 O, pH 7) in a fresh microcentrifuge tube. After incubation at 371C for 30 min, 500 ml of 1 M sodium carbonate solution was added to each sample and the absorbance at 420 nm was measured for the b-galactosidase activity. All in vivo experiments were conducted in triplicate and the average results were recorded. The protein concentration of each lysate sample was assayed by the Lowry kit (Nacalai tesque, Japan). Briefly, 50 ml of lysate was mixed with 1 ml of the copper solution and allowed to stand at 251C for 10 min. Then, 0.1 ml of 1 N phenol aqueous solution was added and the mixture was incubated for 30 min at 251C. The absorbance was recorded at a wavelength of 750 nm and the protein concentration was calculated based on the calibration curve prepared by use of standard albumin bovine solution.
